Development of pulmonary sarcoidosis in Crohn’s disease patient under infliximab biosimilar treatment after long-term original infliximab treatment: a case report and literature review
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-230X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Development of pulmonary sarcoidosis in Crohn’s disease patient under infliximab biosimilar treatment after long-term original infliximab treatment: a case report and literature review ; volume:21 ; number:1 ; day:12 ; month:10 ; year:2021 ; pages:1-7 ; date:12.2021
BMC gastroenterology ; 21, Heft 1 (12.10.2021), 1-7, 12.2021
- Urheber
-
Kashima, Shin
Moriichi, Kentaro
Ando, Katsuyoshi
Ueno, Nobuhiro
Tanabe, Hiroki
Yuzawa, Sayaka
Fujiya, Mikihiro
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12876-021-01948-6
- URN
-
urn:nbn:de:101:1-2021122620012782492651
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2024, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kashima, Shin
- Moriichi, Kentaro
- Ando, Katsuyoshi
- Ueno, Nobuhiro
- Tanabe, Hiroki
- Yuzawa, Sayaka
- Fujiya, Mikihiro
- SpringerLink (Online service)
Ähnliche Objekte (12)
Subcutaneous infliximab in Crohn’s disease patients with previous immunogenic failure of intravenous infliximab
Efficacy of Infliximab for the Treatment of Oral Manifestation of Crohn’s Disease
Hodgkin's Lymphoma in Crohn's Disease Treated with Infliximab
PF-06438179/GP1111: An Infliximab Biosimilar
Infliximab response associates with radiologic findings in bio-naïve Crohn’s disease
Comparison between infliximab and adalimumab in the treatment of perianal fistulas in Crohn's disease
One Case of Epstein–Barr Virus Encephalitis from Pediatric Crohn’s Disease After 6-Mercaptopurine and Infliximab Treatment
Infliximab‐induced seizures in a patient with Crohn’s disease: a case report
Buccal localization of Crohn’s disease with long-term infliximab therapy: a case report
Correction to: PF-06438179/GP1111: An Infliximab Biosimilar
Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s disease
Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases
Subcutaneous infliximab in Crohn’s disease patients with previous immunogenic failure of intravenous infliximab
Efficacy of Infliximab for the Treatment of Oral Manifestation of Crohn’s Disease
Hodgkin's Lymphoma in Crohn's Disease Treated with Infliximab
PF-06438179/GP1111: An Infliximab Biosimilar
Infliximab response associates with radiologic findings in bio-naïve Crohn’s disease
Comparison between infliximab and adalimumab in the treatment of perianal fistulas in Crohn's disease
One Case of Epstein–Barr Virus Encephalitis from Pediatric Crohn’s Disease After 6-Mercaptopurine and Infliximab Treatment
Infliximab‐induced seizures in a patient with Crohn’s disease: a case report
Buccal localization of Crohn’s disease with long-term infliximab therapy: a case report
Correction to: PF-06438179/GP1111: An Infliximab Biosimilar
Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s disease
Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases
Subcutaneous infliximab in Crohn’s disease patients with previous immunogenic failure of intravenous infliximab
Efficacy of Infliximab for the Treatment of Oral Manifestation of Crohn’s Disease
Hodgkin's Lymphoma in Crohn's Disease Treated with Infliximab
PF-06438179/GP1111: An Infliximab Biosimilar
Infliximab response associates with radiologic findings in bio-naïve Crohn’s disease
Comparison between infliximab and adalimumab in the treatment of perianal fistulas in Crohn's disease
One Case of Epstein–Barr Virus Encephalitis from Pediatric Crohn’s Disease After 6-Mercaptopurine and Infliximab Treatment
Infliximab‐induced seizures in a patient with Crohn’s disease: a case report
Buccal localization of Crohn’s disease with long-term infliximab therapy: a case report
Correction to: PF-06438179/GP1111: An Infliximab Biosimilar
Prognostic factors for the efficacy of infliximab in patients with luminal fistulizing Crohn’s disease